News Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 23/04/2025 BST			5-day change	1st Jan Change
587.85 ^USD	+0.40%		+2.94%	-17.48%

04-23	Truist Adjusts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Maintains Buy Rating	MT
04-23	TD Cowen Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $970, Maintains Buy Rating	MT

Truist Adjusts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Maintains Buy Rating	04-23	MT
TD Cowen Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $970, Maintains Buy Rating	04-23	MT
Wells Fargo Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $900, Maintains Overweight Rating	04-23	MT
Truist Cuts Price Target on Regeneron Pharmaceuticals to $975 From $1,004, Keeps Buy Rating	04-23	MT
FUJIFILM Holdings' Unit Secures $3 Billion, 10-Year Biologics Manufacturing Deal with Regeneron	04-23	MT
Japan's Nikkei ends at 3-week high on Wall Street rebound, tech boost	04-23	RE
Japan's Nikkei tracks Wall Street rebound, jumps to three-week high	04-23	RE
Sector Update: Health Care Stocks Rise in Afternoon Trading	04-22	MT
How companies are responding to Trump's tariffs	04-22	RE
How companies are responding to Trump's tariffs	04-22	RE
Regeneron to invest over $3 billion to boost US manufacturing	04-22	RE
Trump set his sights on Jerome Powell	04-22
Canaccord Genuity Adjusts Price Target on Regeneron Pharmaceuticals to $850 From $1,152, Maintains Buy Rating	04-22	MT
Regeneron Partners With Fujifilm to Expand Manufacturing Capacity	04-22	DJ
Regeneron to invest over $3 billion to boost US manufacturing	04-22	RE
Regeneron to Expand US Biologics Production Through $3 Billion Fujifilm Deal	04-22	MT
Regeneron signs over $3 billion deal with contract drugmaker to boost US manufacturing	04-22	RE
Fujifilm Diosynth Biotechnologies And Regeneron Sign 10-Year U.S. Manufacturing Agreement	04-22	RE
Regeneron Announces New Investment In Manufacturing Of Its Biologic Medicines	04-22	RE
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines	04-22	GL
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines	04-22	AQ
Regeneron Announces New Investment in Manufacturing of its Biologic Medicines	04-22	CI
Regeneron Announces Investor Conference Presentations	04-21	GL
Wolfe Research Adjusts Regeneron Pharmaceuticals PT to $950 From $1,000, Keeps Outperform Rating	04-21	MT
Regeneron's FDA Setback on Eylea HD Dosing 'No Biggie,' Says Oppenheimer	04-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline

January 14, 2025 at 05:24 pm